For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
The balance of protein health within cells, a process known as proteostasis, is critical for maintaining cellular ...
A study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...
SALT LAKE CITY — After years of stagnation in the search for a cure for Alzheimer's — or at least breakthroughs — 2024 ...
Alzheimer’s disease is the most common cause of dementia in older adults. But according to experts, the condition affects men ...